SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Talal N, Flescher N. Rheumatoid arthritis: an editorial perspective based on cytoine imbalance. J Autoimmun 1988; 1:30917.
  • 2
    Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990; 86:17908.
  • 3
    Rubin LA, Snow KM, Kurman DL, Nelson DL, Keystone EC. Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity. J Rheumatol 1990; 17:597602.
  • 4
    Dayer J-M, Beutler B, Cerami A. Cachetin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985; 162:21638.
  • 5
    Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by synovial cells. J Clin Invest 1986; 77:6458.
  • 6
    Postlethwaite AF, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH. Modulation of fibroblast functional by interleukin 1: increased steady-state accumulation of Type 1 procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1-alpha and beta. J Cell Biol 1988; 106:3118.
  • 7
    Varga J, Jiminez SA. Stimulation of normal human fibroblast collagen production and processing by transforming growth factor beta. Biochem Biophys Res Commun 1986; 138:97480.
  • 8
    Lotz M, Jirik FV, Kabidouris P, Troukas C, Hirano T, Kishimoto T, Carson DA. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167:12538.
  • 9
    Nakagawa T, Hirano T, Nakagawa N, Yoshizaki K, Kishimoto T. Effect of recombinant IL-2 and IFN-gamma on proliferation and differentiation of human B cells. J Immunol 1985; 134:95966.
  • 10
    Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in Cartilage destruction and repair. Br J Rheumatol 1942; 31:65361.
  • 11
    Firestein GS, Xu W, Townsend K, Broide D, Alvaro-Gracia J, Glasebrook A, Zvaifler NJ. Cytokines in chronic inflammatory arlhritis.1. Failure to detect T cell lymphokines (interleukin 2 and interleukin.3) and presence of colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 1988; 168:157386.
  • 12
    Miossec P, Naviliat M, Dupuy D'angeac A, Sany J, Banchereau J. Low levels of interleukin-4 and high levels of transforming growth factor β in rheumatoid synovitis. Arthritis Rheum 1990; 33:11807.
  • 13
    Combe B, Pope RM, Fischbach M, Darnell B, Baron S, Talal N. Interleukin 2 in rheumatoid arthritis: production of and response to interleukin 2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol 1985; 59:5208.
  • 14
    Nouri AM, Panayi GS. Cytokines and the chronic inflammation of rheumatic disease. III. Deficient interleukin 2 production in rheumatoid arthritis is not due to suppressor mechanisms. J Rheumatol 1987; 14:9026.
  • 15
    Husby G, Williams RC Jr. Immunohistochemical studies of interleukin 2 and gamma interferon in rheumatoid arthritis. Arthritis Rheum 1985; 28:17481.
  • 16
    Hertzog PJ, Emery P, Cheetham BF, Mackay IR, Linnane AW. Interferons in rheumatoid arthritis: alterations in production and response related to disease activity. Clin Immunol Immunopathol 1988; 48:192229.
  • 17
    Yocum DE, Esparaza L, Dubry S, Benjamin JB, Volz R, Scuderi P. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol 1989; 122:13145.
  • 18
    Hopkins SJ, Meager A, Cytokines in synovial fluid. II. The presence of tumor necrosis factor and interferon. Clin Exp Immunol 1988; 73:8892.
  • 19
    Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, Dieppe PA. Interleukin 1 alpha and beta production by cells isolated from membranes around aseptically loose total joint replacements. Annal Rheum Dis 1990; 49:63642.
  • 20
    Yamagata N, Kobayashi K, Kasama T et al. Multiple cytokine activities and loss of interleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis. J Rheumatol 1988; 15:16237.
  • 21
    Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993; 36:90110.
  • 22
    Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory athritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor. Arthritis Rheum 1987; 30:86471.
  • 23
    Lemmel EM, Franke M, Gaus W et al. Results of phase-III clinical trial on treatment of rheumatoid arthritis with interferon gamma. Rheumatol Int 1987; 7:12732.
  • 24
    Schober I, Braun R, Reiser H, Munk K, Leroux M, Kirchner H. Ia-positive T lymphocytes are the producer cells of interferon gamma. Exp Cell Res 1984; 152:34856.
  • 25
    Burmester GR, Jahn B, Gramatzki M, Zacher J, Kalden JR. Activated T cells in vivo and in vitro: divergence in expression of Tac and Ia antigens in the monoblastoid small T cells of inflammation and normal T cells activated in vitro. J Immunol 1984; 133:12304.
  • 26
    Cush JJ, Lipsky PE. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 1988; 31:12308.
  • 27
    Tabata H, Ham M, Kitani A et al. Expression of TLiSA1 on T cells from patients with rheumatoid arthritis and systemic lupus eryhematosus. Clin Immunol Immunopathol 1989; 52:36675.
  • 28
    Goto M, Miyamoto T, Nishioka K, Uchida S. T. cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells an: markedly decreased, in rheumatoid synovial fluids. Arthritis Rheum 1987; 30:73743.
  • 29
    Emery P, Gentry KC, Mackay IR, Muirden KD, Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987; 30:84956.
  • 30
    Lasky HP, Bauer K, Pope RM. Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint. Arthritis Rheum 1988; 31:5259.
  • 31
    Reme T, Portier M, Frayssinoux F, Combe B, Miossec P, Favier F, Sany J. T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Phenotyping of multiple synovial sites. Arthritis Rheum 1990; 33:48592.
  • 32
    Schall TJ. The chemokines. In: ThomsonAW, ed. The cytokine handbook. 2nd edn. New York : Academic Press, 1994:41960.
  • 33
    Zachuriae CO, Anderson AO, Thompson HL, Apella E, Mantovani A, Oppenheim JJ, Matsushima K. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibro-sarcoma cell line. J Exp Med 1990; 171:217782.
  • 34
    Rollins BJ, Walz A, Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991; 78:11126.
  • 35
    Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulated adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992; 148:24238.
  • 36
    Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3:16583.
  • 37
    Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993; 260:3558.
  • 38
    Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 1993; 177:18216.
  • 39
    Hachicha M, Rathanaswami P, Schall TJ, McColl SR. Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon gamma. Arthritis Rheum 1993; 36:2634.
  • 40
    Koch AE, Kunkel SL, Harlow LA et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin invest 1992; 90:7729.
  • 41
    Akahoshi T, Wada C, Endo H et al. Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Arthritis Rheum 1993; 36:76271.
  • 42
    Villiger PM, Terkeltraub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992; 149:7227.
  • 43
    Villiger PM, Terkeltaub R, Lotz M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage, induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest 1992; 90:48896.
  • 44
    Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993; 69:8391.
  • 45
    Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993; 268:58349.
  • 46
    Ropes MW, Bennet GA, Cobb S, Jacox R, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 1958; 2:1620.
  • 47
    Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:1569.
  • 48
    Roth MJ, Tanese N, Goff SP. Purification and characterization of murine retroviral reverse transcriptase expressed in E. coli. J Biol Chem 1985; 260:932635.
  • 49
    Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, Krensky AM. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988; 141:101825.